These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 23756090)

  • 1. Glucose-insulin regulation model with subcutaneous insulin injection and evaluation using diabetic inpatients data.
    Wu Z; Chui CK; Hong GS; Khoo E; Chang S
    Comput Methods Programs Biomed; 2013 Aug; 111(2):347-56. PubMed ID: 23756090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An online failure detection method of the glucose sensor-insulin pump system: improved overnight safety of type-1 diabetic subjects.
    Facchinetti A; Del Favero S; Sparacino G; Cobelli C
    IEEE Trans Biomed Eng; 2013 Feb; 60(2):406-16. PubMed ID: 23193300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal H infinity insulin injection control for blood glucose regulation in diabetic patients.
    Chee F; Savkin AV; Fernando TL; Nahavandi S
    IEEE Trans Biomed Eng; 2005 Oct; 52(10):1625-31. PubMed ID: 16235648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On-line adaptive algorithm with glucose prediction capacity for subcutaneous closed loop control of glucose: evaluation under fasting conditions in patients with Type 1 diabetes.
    Schaller HC; Schaupp L; Bodenlenz M; Wilinska ME; Chassin LJ; Wach P; Vering T; Hovorka R; Pieber TR
    Diabet Med; 2006 Jan; 23(1):90-3. PubMed ID: 16409572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neural predictive controller for insulin delivery using the subcutaneous route.
    Trajanoski Z; Wach P
    IEEE Trans Biomed Eng; 1998 Sep; 45(9):1122-34. PubMed ID: 9735562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calculation of the best basal-bolus combination for postprandial glucose control in insulin pump therapy.
    Revert A; Calm R; Vehi J; Bondia J
    IEEE Trans Biomed Eng; 2011 Feb; 58(2):274-81. PubMed ID: 20639170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose dynamics in Type I diabetes: insights from the classic and linear minimal models.
    Fernandez M; Villasana M; Streja D
    Comput Biol Med; 2007 May; 37(5):611-27. PubMed ID: 16867301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fuzzy-based controller for glucose regulation in type-1 diabetic patients by subcutaneous route.
    Campos-Delgado DU; Hernández-Ordoñez M; Femat R; Gordillo-Moscoso A
    IEEE Trans Biomed Eng; 2006 Nov; 53(11):2201-10. PubMed ID: 17073325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of premeal subcutaneous insulin infusion and injection in type I diabetic patients under continuous basal subcutaneous insulin delivery.
    Navascués I; Kerner W; Pfeiffer EF
    Life Support Syst; 1985; 3(3):263-7. PubMed ID: 3900596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Long-term clinical application of wearable artificial endocrine pancreas].
    Konno Y; Nishida K; Shimoda S; Sakakida M; Shichiri M
    Nihon Rinsho; 1997 Nov; 55 Suppl():282-7. PubMed ID: 9434481
    [No Abstract]   [Full Text] [Related]  

  • 11. A gain-scheduling model predictive controller for blood glucose control in type 1 diabetes.
    Abu-Rmileh A; Garcia-Gabin W
    IEEE Trans Biomed Eng; 2010 Oct; 57(10):2478-84. PubMed ID: 19846371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simulation environment to evaluate closed-loop insulin delivery systems in type 1 diabetes.
    Wilinska ME; Chassin LJ; Acerini CL; Allen JM; Dunger DB; Hovorka R
    J Diabetes Sci Technol; 2010 Jan; 4(1):132-44. PubMed ID: 20167177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.
    Raz I; Weiss R; Yegorchikov Y; Bitton G; Nagar R; Pesach B
    Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Studies on the absorption kinetics of subcutaneously administered insulin].
    Misawa K
    Hokkaido Igaku Zasshi; 1989 Nov; 64(6):792-812. PubMed ID: 2691384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A semiclosed-loop algorithm for the control of blood glucose levels in diabetics.
    Fisher ME
    IEEE Trans Biomed Eng; 1991 Jan; 38(1):57-61. PubMed ID: 2026432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical validation of a new control-oriented model of insulin and glucose dynamics in subjects with type 1 diabetes.
    Fabietti PG; Canonico V; Orsini-Federici M; Sarti E; Massi-Benedetti M
    Diabetes Technol Ther; 2007 Aug; 9(4):327-38. PubMed ID: 17705688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of closed-loop subcutaneous insulin infusion algorithm--application of subcutaneous insulin absorption kinetics.
    Asakawa N; Saito Y; Yamasaki Y; Kawamori R; Shichiri M
    Diabetes Res; 1987 Aug; 5(4):193-8. PubMed ID: 3311559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Closed-loop insulin delivery - what lies between where we are and where we are going?
    Steil GM; Rebrin K
    Expert Opin Drug Deliv; 2005 Mar; 2(2):353-62. PubMed ID: 16296759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induced L₂-norm minimization of glucose-insulin system for Type I diabetic patients.
    Kovács L; Benyó B; Bokor J; Benyó Z
    Comput Methods Programs Biomed; 2011 May; 102(2):105-18. PubMed ID: 20674065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subcutaneous absorption of insulin in insulin-dependent diabetic patients. Influence of species, physico-chemical properties of insulin and physiological factors.
    Hildebrandt P
    Dan Med Bull; 1991 Aug; 38(4):337-46. PubMed ID: 1914533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.